CD4 and neoplasm: The combined OTX008 and anti-PD-1 treatment also led to a significant increase in tumor-infiltrating CD8+ (Figure S14A) and CD4+ T cells (Figure S14B), whereas intratumoral Treg proportions amongst total CD4+ T cells were reduced (Figure S14C).